These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 1305733)
21. Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. Rix M; Eskildsen P; Olgaard K Nephrol Dial Transplant; 2004 Apr; 19(4):870-6. PubMed ID: 15031343 [TBL] [Abstract][Full Text] [Related]
22. Long-term effects of 1 alpha-hydroxycholecalciferol therapy in chronic hemodialysis patients. Rubinger D; Friedlaender MM; Bernheim J; Shachner E; Ronen M; Czaczkes WJ Isr J Med Sci; 1982 Oct; 18(10):1019-26. PubMed ID: 7174269 [TBL] [Abstract][Full Text] [Related]
23. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study. Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187 [TBL] [Abstract][Full Text] [Related]
24. [Particularly severe calcium metabolic disorder in nephropathy from analgesic abuse]. Jaeger P; Burckhardt P; Wauters JP; Trechsel U; Bonjour JP Schweiz Med Wochenschr; 1982 Dec; 112(49):1791-4. PubMed ID: 7178876 [TBL] [Abstract][Full Text] [Related]
25. [The effect of 1alpha-hydroxycholecalciferol on the abnormal calcium metabolism in hemodialysis patients.--Studies on patients showing low serum calcium and high alkaline phosphatase (author's transl)]. Asai K; Ohkura T; Sakamoto N; Kawahara H; Yamazaki C Nihon Jinzo Gakkai Shi; 1978 Sep; 20(9):967-77. PubMed ID: 713173 [No Abstract] [Full Text] [Related]
26. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease. Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548 [TBL] [Abstract][Full Text] [Related]
28. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
29. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP; Leung KT; Tong MK; Kwan TH Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385 [TBL] [Abstract][Full Text] [Related]
30. Correlation of serum parathormone level with biochemical parameters in chronic renal failure. Rahman MH; Hossain MM; Sultana S; Jamal CY; Karim MA Indian Pediatr; 2005 Mar; 42(3):250-4. PubMed ID: 15817973 [TBL] [Abstract][Full Text] [Related]
31. [The value of fingernail creatinine measurement in the identification of acute and chronic renal failure]. Li JZ; Han J; Wang HY Zhonghua Nei Ke Za Zhi; 1992 Jan; 31(1):11-4, 59. PubMed ID: 1395904 [TBL] [Abstract][Full Text] [Related]
32. I alpha-hydroxycholecalciferol: a treatment of renal bone disease. Catto GR; MacLeod M; Pelc B; Kodicek E Br Med J; 1975 Jan; 1(5948):12-4. PubMed ID: 1120218 [TBL] [Abstract][Full Text] [Related]
33. [A study on calcium metabolism in renal failure--clinical aspects and treatment (author's transl)]. Asai K; Watanabe Y; Ohkura T; Sakamoto N Nihon Jinzo Gakkai Shi; 1980 Nov; 22(11):1505-21. PubMed ID: 7206329 [No Abstract] [Full Text] [Related]
34. Curative effects of 1alpha-hydroxycholecalciferol on calcium metabolism and bone disease in patients with chronic renal failure. Hirooka M; Wako H; Kaneko C; Ishikawa M; Sasaki S J Nutr Sci Vitaminol (Tokyo); 1975; 21(4):277-85. PubMed ID: 1214180 [TBL] [Abstract][Full Text] [Related]
36. Effect of treatment with dihydrotachysterol on renal function in patients with chronic renal failure. Cordy PE; Hodsman AB Miner Electrolyte Metab; 1984; 10(5):281-5. PubMed ID: 6493156 [TBL] [Abstract][Full Text] [Related]
39. The treatment of uraemic osteopathy. II. The effect of 5,6-trans-25-hydroxycholecalciferol in terminal renal failure. von Herrath D; Kraft D; Grigoleit H; Schaefer K Ger Med; 1973; 3(3-4):93-5. PubMed ID: 4803059 [No Abstract] [Full Text] [Related]
40. [Treatment of chronic kidney failure by the keto-analogs of essential amino acids: 4 years' experience]. Jungers P; Chauveau P; Lebkiri B; Ciancioni C; Man NK; Crosnier J Presse Med; 1987 Jun; 16(21):1039-43. PubMed ID: 2955325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]